{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:51:31Z","timestamp":1791492691403,"version":"4.3.4"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015629","name":"Jerome L. Greene Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015629","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006260","name":"Rheumatology Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006260","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.semarthrit.2026.152947","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:17:48Z","timestamp":1771287468000},"page":"152947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical characteristics and risk factors associated with objective flares in patients with dermatomyositis"],"prefix":"10.1016","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1675-597X","authenticated-orcid":false,"given":"Didem","family":"Saygin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing Yao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn C.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jemima","family":"Albayda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie J","family":"Paik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Tiniakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Mammen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Christopher-Stine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A","family":"Mecoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.semarthrit.2026.152947_bib0001","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1002\/art.24904","article-title":"Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index","volume":"60","author":"Rider","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.semarthrit.2026.152947_bib0002","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1136\/ard.2005.045690","article-title":"Long-term outcome in polymyositis and dermatomyositis","volume":"65","author":"Bronner","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2026.152947_bib0003","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1471-2377-11-143","article-title":"Clinical characteristics and favorable long-term outcomes for patients with idiopathic inflammatory myopathies: a retrospective single center study in China","volume":"11","author":"Shu","year":"2011","journal-title":"BMC Neurol"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.152947_bib0004","first-page":"2230","article-title":"Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis","volume":"28","author":"Marie","year":"2001","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.152947_bib0005","first-page":"188","article-title":"Retrospective analysis of the outcome of patients with idiopathic inflammatory myopathy: a long-term follow-up study","volume":"32","author":"Taborda","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.152947_bib0006","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1007\/s00415-014-7313-z","article-title":"Long-term follow-up of 62 patients with myositis","volume":"261","author":"van de Vlekkert","year":"2014","journal-title":"J Neurol"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.152947_bib0007","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.autrev.2014.08.023","article-title":"Impact of treatment on survival in polymyositis and dermatomyositis. A single-centre long-term follow-up study","volume":"13","author":"Danieli","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.152947_bib0008","first-page":"820","article-title":"Why do patients with myositis die? A retrospective analysis of a single-centre cohort","volume":"34","author":"Amaral Silva","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2026.152947_bib0009","first-page":"1424","article-title":"Patient-reported dermatomyositis and polymyositis flare symptoms are associated with disability, productivity loss, and health care resource use","volume":"26","author":"Christopher-Stine","year":"2020","journal-title":"J Manag Care Spec Pharm"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.152947_bib0010","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1093\/rheumatology\/kead692","article-title":"Remotely collected patient-reported data characterises the impact of idiopathic inflammatory myopathy flares upon work productivity","volume":"63","author":"Williams","year":"2024","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.semarthrit.2026.152947_bib0011","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.18553\/jmcp.2020.26.11.1424","article-title":"Patient-reported dermatomyositis and polymyositis flare symptoms are associated with disability, productivity loss, and health care resource use","volume":"26","author":"Christopher-Stine","year":"2020","journal-title":"J Manag Care Special Pharm"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.152947_bib0012","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1002\/art.21291","article-title":"International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies","volume":"52","author":"Oddis","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.semarthrit.2026.152947_bib0013","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.semarthrit.2026.152947_bib0014","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1093\/rheumatology\/keac161","article-title":"Investigating characteristics of idiopathic inflammatory myopathy flares using daily symptom data collected via a smartphone app","volume":"61","author":"Oldroyd","year":"2022","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.semarthrit.2026.152947_bib0015","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/rheumatology\/kex162","article-title":"Environmental factors associated with disease flare in juvenile and adult dermatomyositis","volume":"56","author":"Mamyrova","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2026.152947_bib0016","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s41927-020-00146-3","article-title":"Patient insights on living with idiopathic inflammatory myopathy and the limitations of disease activity measurement methods - a qualitative study","volume":"4","author":"Oldroyd","year":"2020","journal-title":"BMC Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152947_bib0017","doi-asserted-by":"crossref","first-page":"R22","DOI":"10.1186\/ar3704","article-title":"Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine","volume":"14","author":"Schiopu","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.152947_bib0018","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/rheumatology\/kex021","article-title":"A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies","volume":"56","author":"Pinal-Fernandez","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2026.152947_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2017.01.046","article-title":"Income, and disease outcomes in juvenile dermatomyositis","volume":"184","author":"Phillippi","year":"2017","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.152947_bib0020","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJM199202063260602","article-title":"Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study","volume":"326","author":"Sigurgeirsson","year":"1992","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.152947_bib0021","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/art.42311","article-title":"Subsets of idiopathic inflammatory myositis enriched for contemporaneous cancer relative to the general population","volume":"75","author":"Mecoli","year":"2023","journal-title":"Arthrit Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.152947_bib0022","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-025-07398-9","article-title":"Clinical features and risk factors of flare in anti-synthetase syndrome","author":"Hasegawa","year":"2025","journal-title":"Clin Rheumatol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017226000363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017226000363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:42:53Z","timestamp":1791492173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017226000363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":22,"alternative-id":["S0049017226000363"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2026.152947","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics and risk factors associated with objective flares in patients with dermatomyositis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2026.152947","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152947"}}